Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Varga

Showing results (181-190 of 297) with videos related to

Pageof 30
Sort By:
The American Journal of Pathology|March 28, 2024
TGF-β1 Drives Integrin-Dependent Pericyte Migration and Microvascular Destabilization in Fibrotic DiseaseAmanda S Pellowe, Michelle J Wu, Tae-Yun Kang, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|December 29, 2016
Nrf2 exerts cell-autonomous antifibrotic effects: compromised function in systemic sclerosis and therapeutic rescue with a novel heterocyclic chalcone derivativeJun Wei, Hongyan Zhu, Gabriel Lord, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 7, 2016
Toll-like Receptor 9 Signaling Is Augmented in Systemic Sclerosis and Elicits Transforming Growth Factor β-Dependent Fibroblast ActivationFeng Fang, Roberta Goncalves Marangoni, Xingchun Zhou, et al.
Arthritis Research & Therapy|May 7, 2026
Aurora A kinase activation contributes to the fibrotic phenotype in systemic sclerosis through primary cilia shorteningRebecca Wells, Begoña Caballero-Ruiz, Panji Mulipa, et al.
Journal of Clinical Medicine|October 16, 2024
Elevated Circulating Levels of Gut Microbe-Derived Trimethylamine <i>N</i>-Oxide Are Associated with Systemic SclerosisKaren J Ho, Lutfiyya N Muhammad, Linh Ngo Khanh, et al.
JCI Insight|June 12, 2023
Pharmacological inhibition of TAK1 prevents and induces regression of experimental organ fibrosisSwarna Bale, Priyanka Verma, Bharath Yalavarthi, et al.
The American Journal of Pathology|September 6, 2008
Smad-independent transforming growth factor-beta regulation of early growth response-1 and sustained expression in fibrosis: implications for sclerodermaSwati Bhattacharyya, Shu-Jen Chen, Minghua Wu, et al.
Cancer Research|October 6, 2005
Role of the p38 mitogen-activated protein kinase pathway in cytokine-mediated hematopoietic suppression in myelodysplastic syndromesEfstratios Katsoulidis, Yongzhong Li, Patrick Yoon, et al.
Journal of Bacteriology|April 21, 2009
Quorum-sensing control of antibiotic synthesis in Burkholderia thailandensisBreck A Duerkop, John Varga, Josephine R Chandler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 25, 2012
Chitinase 1 is a biomarker for and therapeutic target in scleroderma-associated interstitial lung disease that augments TGF-β1 signalingChun Geun Lee, Erica L Herzog, Farida Ahangari, et al.
Pageof 30

Showing results (181-190 of 297) with videos related to

Sort By:
Pageof 30
The American Journal of Pathology|March 28, 2024
TGF-β1 Drives Integrin-Dependent Pericyte Migration and Microvascular Destabilization in Fibrotic DiseaseAmanda S Pellowe, Michelle J Wu, Tae-Yun Kang, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|December 29, 2016
Nrf2 exerts cell-autonomous antifibrotic effects: compromised function in systemic sclerosis and therapeutic rescue with a novel heterocyclic chalcone derivativeJun Wei, Hongyan Zhu, Gabriel Lord, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 7, 2016
Toll-like Receptor 9 Signaling Is Augmented in Systemic Sclerosis and Elicits Transforming Growth Factor β-Dependent Fibroblast ActivationFeng Fang, Roberta Goncalves Marangoni, Xingchun Zhou, et al.
Arthritis Research & Therapy|May 7, 2026
Aurora A kinase activation contributes to the fibrotic phenotype in systemic sclerosis through primary cilia shorteningRebecca Wells, Begoña Caballero-Ruiz, Panji Mulipa, et al.
Journal of Clinical Medicine|October 16, 2024
Elevated Circulating Levels of Gut Microbe-Derived Trimethylamine <i>N</i>-Oxide Are Associated with Systemic SclerosisKaren J Ho, Lutfiyya N Muhammad, Linh Ngo Khanh, et al.
JCI Insight|June 12, 2023
Pharmacological inhibition of TAK1 prevents and induces regression of experimental organ fibrosisSwarna Bale, Priyanka Verma, Bharath Yalavarthi, et al.
The American Journal of Pathology|September 6, 2008
Smad-independent transforming growth factor-beta regulation of early growth response-1 and sustained expression in fibrosis: implications for sclerodermaSwati Bhattacharyya, Shu-Jen Chen, Minghua Wu, et al.
Cancer Research|October 6, 2005
Role of the p38 mitogen-activated protein kinase pathway in cytokine-mediated hematopoietic suppression in myelodysplastic syndromesEfstratios Katsoulidis, Yongzhong Li, Patrick Yoon, et al.
Journal of Bacteriology|April 21, 2009
Quorum-sensing control of antibiotic synthesis in Burkholderia thailandensisBreck A Duerkop, John Varga, Josephine R Chandler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 25, 2012
Chitinase 1 is a biomarker for and therapeutic target in scleroderma-associated interstitial lung disease that augments TGF-β1 signalingChun Geun Lee, Erica L Herzog, Farida Ahangari, et al.
Pageof 30